This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Orion Corporation. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Shouming Wang: Innovator in Pharmaceutical Chemistry
Introduction
Shouming Wang is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the nervous system. His work is characterized by a focus on innovative solutions for treating various diseases.
Latest Patents
Wang holds a patent for a compound titled "2-(1-heteroarylpiperazin-4-yl)methyl-1,4-benzodioxane derivatives as alpha2C antagonists." This patent describes compounds of formula I, wherein A is an optionally substituted five-membered unsaturated heterocyclic ring containing 1, 2, or 3 N, O, or S ring heteroatom(s). These compounds exhibit alpha2C antagonistic activity, making them useful for the treatment of diseases or conditions affecting the peripheral or central nervous system. He has 1 patent to his name.
Career Highlights
Shouming Wang is associated with Orion Corporation, a leading company in the pharmaceutical industry. His role at Orion has allowed him to engage in cutting-edge research and development, contributing to the advancement of medical therapies.
Collaborations
Wang has collaborated with esteemed colleagues such as Esa Kumpulainen and Jarmo J Pystynen. These partnerships have fostered a collaborative environment that enhances innovation and the development of new therapeutic solutions.
Conclusion
Shouming Wang's contributions to pharmaceutical chemistry and his innovative patent work exemplify his commitment to advancing medical science. His ongoing research continues to hold promise for the treatment of various neurological conditions.